Table 2.
MVA for 3‐Month Survival on Waiting List
| Parameter | Univariate Analysis | MVA | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P Value | OR | 95% CI | P Value | |
| vWF‐Ag (%) | 1.005 | 1.002, 1.007 | 0.001 | 1.003 | 1.001, 1.006 | 0.036 |
| MELD‐Na | 1.180 | 1.098, 1.268 | <0.001 | 1.154 | 1.068, 1.246 | <0.001 |
| CLIF‐C AD | 1.082 | 0.974, 1.203 | 0.141 | — | — | — |
| Sex | 0.770 | 0.335, 1.767 | 0.537 | — | — | — |
| Age at listing | 1.021 | 0.981, 1.062 | 0.310 | — | — | — |
| Circulating parameters at listing | ||||||
| PT (%) | 0.970 | 0.945, 0.995 | 0.021 | 1.015 | 0.987, 1.044 | 0.284 |
| aPTT (seconds) | 1.046 | 0.984, 1.113 | 0.149 | — | — | — |
| AST (U/L) | 0.999 | 0.994, 1.004 | 0.683 | — | — | — |
| ALT (U/L) | 0.997 | 0.988, 1.007 | 0.586 | — | — | — |
| Bilirubin (mg/dL) | 1.058 | 1.011, 1.108 | 0.016 | 0.974 | 0.910, 1.043 | 0.450 |
| AP (U/L) | 1.000 | 0.998, 1.002 | 0.832 | — | — | — |
| GGT (U/L) | 0.997 | 0.992, 1.003 | 0.331 | — | — | — |
| Indication for LTx | ||||||
| Alcohol‐associated cirrhosis | 1.790 | 0.838, 3.821 | 0.132 | — | — | |
| Tumor | 0.097 | 0.013, 0.724 | 0.023 | 0.000 | NA | 0.998 |
| Viral hepatitis (B+C) | 0.547 | 0.158, 1.888 | 0.340 | — | — | — |
| Biliary disorders | 0.327 | 0.043, 2.517 | 0.283 | — | — | — |
| Autoimmune hepatitis | 4.893 | 1.525, 15.703 | 0.008 | 1.527 | 0.295, 7.900 | 0.613 |
| Cryptogenic cirrhosis | 3.770 | 1.087, 13.072 | 0.036 | 3.851 | 1.031, 14.384 | 0.045 |
| Other indications | 1.002 | 0.282, 3.552 | 0.998 | — | — | — |
Abbreviations: CLIF‐C AD, chronic liver failure acute decompensation score; LTx, liver transplant; NA, not available.